Inspira Technologies Ltd., a leader in respiratory medical technology, announced appointing of Professor Benad Goldwasser as Chairman of the Board of Directors. Prof. Goldwasser brings extensive experience in the founding, development and successful exits of several medical device companies over the past three decades. As Chairman of the Board, Prof. Goldwasser will leverage his expertise in leading high growth, publicly traded companies to help drive the long-term development of Inspira Technologies’ medical device portfolio.
Following his career as a urologic surgeon, Prof. Goldwasser became a prolific entrepreneur and business executive in the healthcare industry. In 1993, he co-founded Vidamed Inc., that was later sold to Medtronic Inc. He then co-founded Medinol Ltd., one of Israel’s most successful medical device firms, which partnered with Boston Scientific in the sales and marketing of its industry-leading coronary stents. As co-founder and MD of venture capital company Biomedical Investments Ltd., he oversaw several successful exits, including the sale of Colbar Ltd. to Johnson & Johnson.
Professor Benad Goldwasser said, “I was immediately impressed by Inspira Technologies’ vision, which has the opportunity to gain a significant market share in the respiratory support device industry. Inspira’s solution extends respiratory treatment to patients who would otherwise be treated with mechanical ventilation or would not be treated at all due to lack of access to intensive care. As Chairman of the Board, I look forward to joining Inspira’s long-term journey and helping to change the way respiratory patients are treated.”
“Professor Benad is a healthcare veteran with an unmatched history of leading medical device innovations through rapid periods of growth,” said Dagi Ben-Noon, co-founder and CEO of Inspira.
